Status and phase
Conditions
Treatments
About
The purpose of this study is to determine efficacy differences between ALTO-100 and placebo, used either as monotherapy or adjunctively to an antidepressant, related to patient characteristics.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
301 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Alto Neuroscience
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal